The newly established CAB has been formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The CAB ...

Psychotropic drugs are all the rage now as a potential treatment of brain diseases. Examples are ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have ...

Please provide your email address to receive an email when new articles are posted on . NEW YORK — One dose of lysergide produced clinical remission of generalized anxiety disorder as soon as 4 weeks ...

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

If you receive a denial letter from your insurer, seek legal advice before appealing the decision, says a leading disability ...

The U.S. Food and Drug Administration last week granted “breakthrough therapy” status to a form of the psychedelic drug LSD as a treatment for anxiety. The drug, a form of LSD (lysergide d-tartrate) ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Inc. has recently rebranded as Deinium Therapeutics Inc., is changing its Nasdaq ticker to DFTX, and outlined a late-stage ...

NEW YORK--(BUSINESS WIRE)--Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

A recent study of a million people with 14 psychiatric disorders showed these disorders fell into five genetic clusters.